Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

Efficacy and Safety of Once-Weekly Cyclophosphamide-Bortezomib-Dexamethasone (CBD) Regimen As Induction Therapy Prior to Autologous Stem Cell Transplantation in Japanese Patients with Newly Diagnosed Multiple Myeloma. -a Phase 2 Multicenter Trial-

Blood (2018) 132 (Supplement 1): 2160.

https://doi.org/10.1182/blood-2018-99-113788

Published: 2018

Journal Articles

Comprehensive Analysis of Serum Cytokines/Chemokines in Myeloma Patients for Pursuing the Abnormality in Microenvironment and Predicting the Prognosis

Yukiko Cho, PhD, Katsushige Inada, PhD, Yasushi Okoshi, MD PhD, Mitsuo Hori, MD PhD, Hiroshi Kojima, MD PhD

Blood (2016) 128 (22): 2083.

https://doi.org/10.1182/blood.V128.22.2083.2083

Published: 2016

Journal Articles

Availability of Circulating microRNAs As a Biomarker for the Early Diagnosis of Diffuse Large B-Cell Lymphoma

Katsushige Inada, PhD, Yasushi Okoshi, MD PhD, Yukiko Cho, PhD, Hitoaki Saito, MD PhD, Tatsuo Iijima, MD PhD, Mitsuo Hori, MD PhD, Hiroshi Kojima, MD PhD

Blood (2014) 124 (21): 2988.

https://doi.org/10.1182/blood.V124.21.2988.2988

Published: 2014

Journal Articles

Relevance of the Daily Dose of Imatinib Mesylate (IM) Rather Than Its Trough Plasma Concentration for Achieving Deep Molecular Response in Patients with Chronic Myeloid Leukemia.

Chikashi Yoshida, MD, PhD, Takuya Komeno, MD, MPH, PhD, Mitsuo Hori, MD, PhD, Tomofumi Kimura, MD, PhD, Masami Fujii, MD, PhD, Yasushi Okoshi, MD, PhD, Kazumi Suzukawa, MD, PhD, Shigeru Chiba, MD, PhD, Yuichi Hasegawa, MD, PhD, Harumi Yamamoto Mukai, MD, PhD, Takayoshi Ito, MD, PhD, Seiichi Shimizu, MD, PhD, Masaharu Kamoshita, MD, PhD, Daisuke Kudo, MD, Atsushi Shinagawa, MD, PhD, Norio Chikatsu, MD, PhD, Yuriko Monma, MD, Norimichi Watanabe, MD, PhD, Hiroshi Kojima, MD, PhD

Blood (2009) 114 (22): 1112.

https://doi.org/10.1182/blood.V114.22.1112.1112

Published: 2009

Journal Articles

The Critical Function of c-Myb and CD9 On Megakaryopoiesis.

Harumi Yamamoto Mukai, MD, PhD, Tomoko Kouno, Hozumi Motohashi, Yukinori Kozuma, Hiroshi Kojima, MD, PhD, Haruhiko Ninomiya, MD, PhD, Masayuki Yamamoto, MD, PhD

Blood (2009) 114 (22): 4587.

https://doi.org/10.1182/blood.V114.22.4587.4587

Published: 2009

Journal Articles

Functional Analysis of CD9 during Megakaryopoiesis

Tomoko Kono, Harumi Mukai, MD, PhD, Yukinori Kozuma, Hiroshi Kojima, MD, PhD, Haruhiko Ninomiya, MD, PhD

Blood (2008) 112 (11): 891.

https://doi.org/10.1182/blood.V112.11.891.891

Published: 2008

Journal Articles

PNH-Affected RBC’s Mean Life Span Estimated by Reticulocyte-Gated Flow Cytometry Reflects In Vivo Hemolysis in PNH.

Haruhiko Ninomiya, MD, Shoko Sato, Yuichi Hasegawa, MD, Hiroshi Kojima, MD, Toshiro Nagasawa, MD

Blood (2007) 110 (11): 3679.

https://doi.org/10.1182/blood.V110.11.3679.3679

Published: 2007

Journal Articles

Caspase-3 Activation Is Involved in the Early Megakaryocyte Differentiation, but Not in Platelet Production.

Yukinori Kozuma, Satoshi Yuki, Hidenori Suzuki, PhD, Hiroshi Kojima, MD, PhD

Blood (2007) 110 (11): 3364.

https://doi.org/10.1182/blood.V110.11.3364.3364

Published: 2007

Journal Articles

GATA-1, Transcriptionally, and Thrombopoietin-Mediated Akt Activation, Post-Translationally, Regulate Continuous Expression of Bcl-xL Protein during Megakaryopoiesis.

Yukinori Kozuma, Hiroshi Kojima, MD, PhD, Satoshi Yuki, Hidenori Suzuki, PhD, Toshiro Nagasawa, MD, PhD

Blood (2006) 108 (11): 1140.

https://doi.org/10.1182/blood.V108.11.1140.1140

Published: 2006

Journal Articles

Regulation of the Anti-Apoptotic Protein, Bcl-xL, during Differentiation of Megakaryocytes from Stem Cells.

Hiroshi Kojima, MD, PhD, Yukinori Kozuma, Toshiro Nagasawa, MD, PhD

Blood (2005) 106 (11): 3146.

https://doi.org/10.1182/blood.V106.11.3146.3146

Published: 2005

NARROW

Efficacy and Safety of Once-Weekly Cyclophosphamide-Bortezomib-Dexamethasone (CBD) Regimen As Induction Therapy Prior to Autologous Stem Cell Transplantation in Japanese Patients with Newly Diagnosed Multiple Myeloma. -a Phase 2 Multicenter Trial-

Comprehensive Analysis of Serum Cytokines/Chemokines in Myeloma Patients for Pursuing the Abnormality in Microenvironment and Predicting the Prognosis

Availability of Circulating microRNAs As a Biomarker for the Early Diagnosis of Diffuse Large B-Cell Lymphoma

Relevance of the Daily Dose of Imatinib Mesylate (IM) Rather Than Its Trough Plasma Concentration for Achieving Deep Molecular Response in Patients with Chronic Myeloid Leukemia.

The Critical Function of c-Myb and CD9 On Megakaryopoiesis.

Functional Analysis of CD9 during Megakaryopoiesis

PNH-Affected RBC’s Mean Life Span Estimated by Reticulocyte-Gated Flow Cytometry Reflects In Vivo Hemolysis in PNH.

Caspase-3 Activation Is Involved in the Early Megakaryocyte Differentiation, but Not in Platelet Production.

GATA-1, Transcriptionally, and Thrombopoietin-Mediated Akt Activation, Post-Translationally, Regulate Continuous Expression of Bcl-xL Protein during Megakaryopoiesis.

Regulation of the Anti-Apoptotic Protein, Bcl-xL, during Differentiation of Megakaryocytes from Stem Cells.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only